Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Type 2 Diabetes
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Flash Glucose Mornitoring will be used in patients with type 2 diabetes who are treated with premixed insulin. The frequency of hypogycemia and the blood glucose control will be analyzed by flash glucose mornitoring once a month for 3 months and doctors will adjust the hypoglycemia treatment accordi...
Flash Glucose Mornitoring will be used in patients with type 2 diabetes who are treated with premixed insulin. The frequency of hypogycemia and the blood glucose control will be analyzed by flash glucose mornitoring once a month for 3 months and doctors will adjust the hypoglycemia treatment according to the results every month. HbA1c, glycemic variation, beta-cell function and androgen levels will be measured.
Tracking Information
- NCT #
- NCT04847219
- Collaborators
- Wuxi Hospital of Traditional Chinese Medicine
- Wuxi People's Hospital Affiliated to Nanjing Medical University
- Huai'an Second People's Hospital and the Affiliated Huai'an Hospital of Xuzhou Medical University
- The Affiliated Suqian First People's Hospital of Nanjing Medical University
- Investigators
- Study Chair: Jianhua Ma, MD The First Affiliated Hospital with Nanjing Medical University
Get Well Soon